Hepatitis B virus (HBV) infection has shown an intermediate or high endemicity level in low-
income countries over the last five decades. In recent years, however, the incidence of acute …

The emergence and takeover of hepatitis B virus (HBV) variants carrying mutation (s) in the
preS/S genomic region is a fairly frequent event that may occur spontaneously or may be the …

Hepatitis B virus (HBV) is one of the most widely distributed viruses that infect humankind.
Distinct clinical and virological characteristics of the HBV‐infection have been reported in …

Hepatitis B virus (HBV) infection is a major cause of acute and chronic hepatitis, and of its
long-term complications. It is the most variable among DNA viruses, mostly because of its …

Direct population sequencing and reverse hybridization (line probe assay [LiPA])-based
methods are the most common methods for detecting hepatitis B virus (HBV) drug resistance …

Hepatitis B virus (HBV) is the leading cause of liver disease and infects an estimated 240
million people worldwide. It is characterised by a high degree of genetic heterogeneity …

Hepatitis B virus (HBV) is the most common cause of hepatitis worldwide, with nearly 350
million people chronically infected and 600000 deaths per year due to acute liver failure …

Complete or almost complete hepatitis B virus (HBV) genomes were sequenced for 13
genotype A and 42 genotype D strains from the former USSR. The strains were classifiable …

Background and aim: Hepatocellular carcinoma (HCC) is a significant complication of
hepatitis B and still poses a global public health concern. This systematic review and meta …

Hepatitis B virus (HBV) subgenotypes may be related to clinical outcomes and response to
antiviral therapy. Most Brazilian studies on HBV subgenotypes are restricted to some …